These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 437918

  • 1. Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.
    Minami A, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H.
    Int J Cancer; 1979 Mar 15; 23(3):358-65. PubMed ID: 437918
    [Abstract] [Full Text] [Related]

  • 2. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A, Kasai M, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H.
    Cancer Res; 1980 Jul 15; 40(7):2129-34. PubMed ID: 6446378
    [Abstract] [Full Text] [Related]

  • 3. Analysis of immunosuppressor cells induced by immunization of solubilized tumor-associated antigens prepared from a rat fibrosarcoma.
    Minami A.
    Nihon Seikeigeka Gakkai Zasshi; 1981 Aug 15; 55(8):779-92. PubMed ID: 6171602
    [Abstract] [Full Text] [Related]

  • 4. Detection of delayed hypersensitivity reaction in rats by radioisotopic footpad assay with sodium deoxycholate extract and mitomycin-C-treated tumor cells.
    Yamada Y, Mizushima Y, Hosokawa M, Kobayashi H.
    Gan; 1978 Aug 15; 69(4):549-55. PubMed ID: 81787
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
    Mizushima Y, Sendo F, Takeichi N, Hosohawa M, Kobayashi H.
    Cancer Res; 1981 Jul 15; 41(7):2917-21. PubMed ID: 6454480
    [Abstract] [Full Text] [Related]

  • 6. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y, Fukushima M, Sato T, Komaba M, Yagihashi H.
    Tohoku J Exp Med; 1971 Feb 15; 103(2):195-201. PubMed ID: 5580594
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
    Hosokawa M, Okayasu T, Ikeda K, Katoh H, Suzuki Y, Kobayashi H.
    Cancer Res; 1983 May 15; 43(5):2301-5. PubMed ID: 6831454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Change of antigenic expression on rat tumor cells after their transplantation.
    Gotohda E, Sendo F, Nakayama M, Hosokawa M, Kawamura T.
    J Natl Cancer Inst; 1975 Nov 15; 55(5):1079-83. PubMed ID: 1206734
    [Abstract] [Full Text] [Related]

  • 14. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
    Poupon MF, Lespinats G, Kolb JP, Payelle B.
    J Natl Cancer Inst; 1979 Apr 15; 62(4):989-94. PubMed ID: 311871
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor resistance in rats immunized to fetal tissues.
    Grant JP, Wells SA.
    J Surg Res; 1974 May 15; 16(5):533-40. PubMed ID: 4831730
    [No Abstract] [Full Text] [Related]

  • 17. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH, Smith RT.
    Int J Cancer; 1978 Jul 15; 22(1):79-90. PubMed ID: 79560
    [Abstract] [Full Text] [Related]

  • 18. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE, Adams JS, Santos GW.
    J Natl Cancer Inst; 1974 Jul 15; 53(1):165-75. PubMed ID: 4600504
    [No Abstract] [Full Text] [Related]

  • 19. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE, Hellström I.
    Int J Cancer; 1981 Jul 15; 27(4):481-5. PubMed ID: 6168591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.